From: Difference in cardiac remodeling between female athletes and pregnant women: a case control study
Parameter | Pregnancy | Athletes | Controls | p (athletes vs pregnant women) | p (pregnant womne vs controls) | p (athletes vs controls) |
---|---|---|---|---|---|---|
EF (%) | 58.9 ± 4.2 | 62.1 ± 6.3 | 63.5 ± 3.4 | 0.08 | 0.06 | 0.36 |
FS (%) | 37.7 ± 5.1 | 41 ± 3.7 | 39.6 ± 4.7 | 0.57 | 0.65 | 0.51 |
MAPSE (mm) | 18.5 ± 1.8 | 19.2 ± 1.7 | 19.8 ± 2.7 | 0.26 | 0.06 | 0.44 |
E/A | 1.28 ± 0.29 | 2.2 ± 0.7 | 1.7 ± 0.4 | < 0.001 | 0.05 | 0.32 |
IVRT (s) | 67 ± 9.9 | 75.6 ± 9.2 | 74.6 ± 8.3 | 0.008 | 0.01 | 0.48 |
DT (m/s) | 169 ± 24 | 182 ± 27.9 | 181.4 ± 25.4 | 0.13 | 0.12 | 0.35 |
E/E’ | 6.1 ± 1.6 | 6 ± 0.7 | 5.76 ± 0.82 | 0.76 | 0.18 | 0.47 |
S (LV) (m/s) | 10.2 ± 1.7 | 10.2 ± 1.1 | 10.8 ± 1.6 | 0.98 | 0.14 | 0.18 |
TAPSE (mm) | 23.7 ± 4.2 | 23.9 ± 3 | 23.5 ± 2.7 | 0.86 | 0.74 | 0.19 |
S (RV) (m/s) | 14.2 ± 2.6 | 12.5 ± 1.5 | 13.1 ± 1.6 | 0.02 | 0.09 | 0.81 |
LV GLS (%) | −23.7 ± 2.9 | −26.5 ± 4.1 | − 26.5 ± 2.8 | 0.02 | 0.05 | 0.68 |
LV GCS (%) | −28.6 ± 4.3 | − 30.7 ± 4.9 | −27.4 ± 3.9 | 0.16 | 0.42 | 0.06 |
RV GLS (%) | −29.8 ± 6.3 | −27.4 ± 3.9 | −26.7 ± 5.8 | 0.03 | 0.02 | 0.54 |